Incremental prognostic value of a novel metabolite ‐based biomarker score in congestive heart failure patients

ConclusionsIn patients with CHF, incorporating a panel of three metabolite ‐based biomarkers into a risk score improved the prognostic utility of NT‐proBNP by predicting long‐term cardiovascular death more precisely. This novel approach holds promise to improve clinical risk assessment in CHF patients.

Source: ESC Heart Failure - August 27, 2020 Category: Cardiology Authors: Peter McGranaghan, Hans ‐Dirk Düngen, Anshul Saxena, Muni Rubens, Joseph Salami, Jasmin Radenkovic, Doris Bach, Svetlana Apostolovic, Goran Loncar, Marija Zdravkovic, Elvis Tahirovic, Jovan Veskovic, Stefan Störk, Emir Veledar, Burkert P Tags: Original Research Article Source Type: research